Progranulin and β-amyloid distribution: A case report of the brain from preclinical ps-1 mutation carrier

American Journal of Alzheimer's Disease and other Dementias

Volumn 24, Issue 6, 2009, Pages 456-460

  Gliebus, Gediminas ^a   Rosso, Andrea ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer?s disease; Progranulin; PS 1 mutation; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; PRESENILIN 1; PROGRANULIN;

ANTIBODY LABELING; ARTICLE; GENE MUTATION; HETEROZYGOTE; HUMAN; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; TEMPORAL LOBE;

EID: 70450284414     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317509346209     Document Type: Article

References (29)

1. Alzheimer?s Disease Facts and Figures 2007. Alzheimer?s Association ; 2007. http://www.alz.org/national/documents/report-alzfactsfigures2007.pdf. Accessed August 24, 2009.
2. Hebert LE, Beckett LA, Scherr PA, Evans DA Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Dis. 2001 ; 15 (4). 169-173.
3. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003 ; 60 (8). 1119-1122.
4. Bynum JP, Rabins PV, Weller W., Niefeld M., Anderson GF, Wu AW The relationship between a dementia diagnosis, chronic illness, Medicare expenditures, and hospital use. J Am Geriatr Soc. 2004 ; 52 (2). 187-194.
5. Larson EB, Shadlen MF, Wang L., et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004 ; 140 (7). 501-509.
6. Langa KM, Chernew ME, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med. 2001 ; 16 (11). 770-778.
7. Ropper AH, Brown RH Adams and Victor?s Principles of Neurology. 8 th ed. New York, NY: McGraw Hill ; 2005: 898-906.
8. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association ; 2000.
9. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991 ; 82 (4). 239-259.
10. Braak H., Braak E. Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol. 1990 ; 80 (5). 479-486.
11. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1991 ; 1 (3). 213-216.
12. Hubbard BM, Fenton GW, Anderson JM A quantitative histological study of early clinical and preclinical Alzheimer?s disease. Neuropathol Appl Neurobiol. 1990 ; 16 (2). 111-121.
13. Ogomori K., Kitamoto T., Tateishi J., et al. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer?s disease. Am J Pathol. 1989 ; 134 (2). 243-251.
14. Tomlinson BE Second Dorothy S. Russell memorial lecture. The neuropathology of Alzheimer?s disease- issues in need of resolution. Neuropathol Appl Neurobiol. 1989 ; 15 (6). 491-512.
15. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999 ; 58 (11). 1147-1155.
16. Eriksen JL, Mackenzie RA Progranulin: normal function and role in neurodegeneration. J Neurochem. 2008 ; 104 (2). 287-297.
17. Baker M., Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006 ; 442 (7105). 916-919. (Pubitemid 44285946)
18. Malaspina A., Kaushik N., de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem. 2001 ; 77 (1). 132-145.
19. He Z., Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med. 2003 ; 81 (10). 600-612. (Pubitemid 37357675)
20. Cruts M., Gijselinck I., van der Zee J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006 ; 442 (7105). 920-924. (Pubitemid 44285947)
21. Tangkeangsirisin W., Serrero G. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis. 2004 ; 25 (9). 1587-1592.
22. Ahmed Z., Mackenzie IR, Hutton Ml, Dickson DW Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation. 2007 ; 4: 7.
23. Alzheimer?s Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995 ; 11 (2). 219-222.
24. Mira SS, Heyman A., McKeel D., et al. The Consortium to Establish a Registry for Alzheimer?s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer?s Disease. Neurology. 1991 ; 41 (4). 479-486.
25. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer?s Disease. Neurobiol Aging. 2000 ; 21 (3). 383-421.
26. Eikelenboom P., Veerhuis R., Familian A., Hoozemans JJ, van Gool WA, Rozemuller AJ Neuroinflammation in plaque and vascular beta-amyloid disorders: clinical and therapeutic implications. Neurodegener Dis. 2008 ; 5 (3-4). 190-193.
27. Rozemuller AJ, van Gool WA, Eikelenboom P. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer?s disease: therapeutic implications. Curr Drug Targets CNS Neurol Dis. 2005 ; 4 (3). 223-233.
28. Eikelenboom P., Veerhuis R., Scheper W., Rozemuller AJ, van Gool WA, Hoozemans JJ The significance of neuroinflammation in understanding Alzheimer?s disease. J Neural Transm. 2006 ; 113 (11). 1685-1695.
29. Eikelenboom P., Veerhuis R. The importance of inflammatory mechanisms for the development of Alzheimer?s disease. Exp Gerontol. 1999 ; 34 (3). 453-461.